BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24497979)

  • 1. Identification of STAT5A and STAT5B target genes in human T cells.
    Kanai T; Seki S; Jenks JA; Kohli A; Kawli T; Martin DP; Snyder M; Bacchetta R; Nadeau KC
    PLoS One; 2014; 9(1):e86790. PubMed ID: 24497979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells.
    Jenks JA; Seki S; Kanai T; Huang J; Morgan AA; Scalco RC; Nath R; Bucayu R; Wit JM; Al-Herz W; Ramadan D; Jorge AA; Bacchetta R; Hwa V; Rosenfeld R; Nadeau KC
    Clin Immunol; 2013 Aug; 148(2):227-36. PubMed ID: 23773921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
    Verdier F; Rabionet R; Gouilleux F; Beisenherz-Huss C; Varlet P; Muller O; Mayeux P; Lacombe C; Gisselbrecht S; Chretien S
    Mol Cell Biol; 1998 Oct; 18(10):5852-60. PubMed ID: 9742102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.
    Tang JZ; Zuo ZH; Kong XJ; Steiner M; Yin Z; Perry JK; Zhu T; Liu DX; Lobie PE
    Endocrinology; 2010 Jan; 151(1):43-55. PubMed ID: 19966185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation.
    Grimley PM; Dong F; Rui H
    Cytokine Growth Factor Rev; 1999 Jun; 10(2):131-57. PubMed ID: 10743504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
    Park SH; Yamashita H; Rui H; Waxman DJ
    Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
    Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
    Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression.
    Wang Y; Jiang H
    J Biol Chem; 2005 Mar; 280(12):10955-63. PubMed ID: 15677453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT5A and STAT5B have opposite correlations with drug response gene expression.
    Lamba V; Jia B; Liang F
    Biochem Biophys Res Commun; 2016 Oct; 479(2):117-124. PubMed ID: 27264955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities.
    Boucheron C; Dumon S; Santos SC; Moriggl R; Hennighausen L; Gisselbrecht S; Gouilleux F
    J Biol Chem; 1998 Dec; 273(51):33936-41. PubMed ID: 9852045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.
    Du W; Wang YC; Hong J; Su WY; Lin YW; Lu R; Xiong H; Fang JY
    J Cell Physiol; 2012 Jun; 227(6):2421-9. PubMed ID: 21826656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR-ABL affects STAT5A and STAT5B differentially.
    Schaller-Schönitz M; Barzan D; Williamson AJ; Griffiths JR; Dallmann I; Battmer K; Ganser A; Whetton AD; Scherr M; Eder M
    PLoS One; 2014; 9(5):e97243. PubMed ID: 24836440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo identification of novel STAT5 target genes.
    Basham B; Sathe M; Grein J; McClanahan T; D'Andrea A; Lees E; Rascle A
    Nucleic Acids Res; 2008 Jun; 36(11):3802-18. PubMed ID: 18492722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
    Moriggl R; Gouilleux-Gruart V; Jähne R; Berchtold S; Gartmann C; Liu X; Hennighausen L; Sotiropoulos A; Groner B; Gouilleux F
    Mol Cell Biol; 1996 Oct; 16(10):5691-700. PubMed ID: 8816482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity.
    Peng B; Sutherland KD; Sum EY; Olayioye M; Wittlin S; Tang TK; Lindeman GJ; Visvader JE
    Mol Endocrinol; 2002 Sep; 16(9):2019-33. PubMed ID: 12198240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor preferentially activates the 94-kD STAT5A and an 80-kD STAT5A isoform in human peripheral blood monocytes.
    Rosen RL; Winestock KD; Chen G; Liu X; Hennighausen L; Finbloom DS
    Blood; 1996 Aug; 88(4):1206-14. PubMed ID: 8695838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a.
    Yip SH; Eguchi R; Grattan DR; Bunn SJ
    J Neuroendocrinol; 2012 Dec; 24(12):1484-91. PubMed ID: 22775396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
    Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
    J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased phosphorylation of STAT5b, but not STAT5a, in nasal polyps.
    Linke R; Pries R; Könnecke M; Bruchhage KL; Böscke R; Gebhard M; Wollenberg B
    Am J Rhinol Allergy; 2015; 29(3):182-7. PubMed ID: 25975249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
    Luo G; Yu-Lee L
    J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.